Very preterm birth: who has access to antenatal corticosteroid therapy?

We describe the administration of antenatal corticosteroid therapy (ACT) for liveborn very preterm neonates in a population-based study. A total of 790 very preterm neonates (between 24 and 31 full weeks of gestation) were included in this regionally defined population of very preterm neonates in France. The main outcome measure was non-access to ACT.

[Very preterm birth: is maternal anesthesia a risk factor for neonatal intubation in the delivery room?].

Objective: To assess the risk of tracheal intubation at birth in very premature neonates related to the type of maternal anesthesia in case of elective cesarean.

Population And Methods: All 219 live-born very premature neonates (28-32 weeks of gestation), delivered after an elective cesarean in the 27 maternity wards of 2 French semi-rural neonatal networks. Eighty-three percent (182/219) were delivered in level III maternity wards in university hospitals.

Self-healing generalized infantile myofibromatosis with elevated urinary bFGF.

We report a case of generalized infantile myofibromatosis with favorable outcome despite systemic involvement. Elevated urinary bFGF levels during the active phase of the disease suggested an angiogenic stimulation in the pathogenesis of myofibromatosis.

[Fetal alcohol syndrome].

Fetal alcohol syndrome is frequently observed. It is estimated that 0.2% of newborns in France have fetal alcohol syndrome, a rate which reaches 1% in certain studies.